Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

19-NEU-3934-glioblastoma-ADAMDEC1-450×650

Novel Pathway Critical to Glioma Stem Cells Identified as Therapeutic Target in Glioblastoma

Newly discovered signaling loop is shown to be druggable

Polyp image – Copy
August 22, 2019/Cancer

New Endoluminal Surgery Center Focuses on Collaboration and Organ-Sparing Interventions for the Gastrointestinal Tract

Goals include reduced morbidity, shorter hospital stays

19-NEU-3900-immunotherapy-650×450
August 20, 2019/Cancer

Immunotherapy for Non-Small Cell Lung Cancer Brain Metastases: Ready for Prime Time

Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition

19-OBG-1300_CQD_650x450_1064521770
August 16, 2019/Cancer

Managing Urogenital and Vulvovaginal Atrophy in Breast Cancer Survivors Receiving Endocrine Therapy

A comprehensive approach to genitourinary syndrome of menopause

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×350-Chemotherapy
August 15, 2019/Cancer/Research

Study Shows Survival Advantage for BEAM Conditioning Regimen in Hodgkin’s Lymphoma

Results prompt clinical practice change

650×450-Lung-Cancer-Radiation

Using Artificial Intelligence to Deliver Personalized Radiation Therapy

Cleveland Clinic-led research employs advanced image analysis to inform dose delivery

Doctor examines patient's neck
August 7, 2019/Cancer

Less is More: Study Discourages Overuse of Imaging in Paraganglioma Surveillance

Study offers new surveillance guidelines for a rare head and neck tumor

Illustration of endometrial cancer
July 22, 2019/Cancer

Endometrial Cancer Outcomes in Women Under 40

Characterizing endometrial cancer in young patients diagnosed before age 40

19-NEU-318 T-cell-activation-650×450

Grant Boosts Efforts to Take on Glioblastoma by Targeting Immunosuppressive Cells

Focus is on inhibiting action of myeloid-derived suppressor cells

Prostate cancer DNA
June 19, 2019/Cancer

PD-L2: A Viable Prognostic Biomarker in Prostate Cancer

This cell surface protein could be an immune checkpoint inhibition target

BackPage 62 of 85Next

Advertisement

Ad